Acetyl-L-carnitine and α-lipoic acid: possible neurotherapeutic agents for mood disorders?

Bibliography

• Kessler R. Comorbidity of unipolar and bipolar depression with other psychiatric disorders in a general population survey. In: editors, Comorbidity in affective disorders. New York: Marcel Dekker, Inc.; 1999. p. 1-25
   Google Scholar
• Kessler RC, Rubinow DR, Holmes C, et al. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997;27:1079-89
   PubMed Web of Science ®Google Scholar
• MacQueen GM, Galway TM, Hay J, et al. Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status. Psychol Med 2002;32:251-8
   PubMed Web of Science ®Google Scholar
• MacQueen GM, Grof P, Alda M, et al. A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder. Bipolar Disord 2004;6:374-8
   PubMed Web of Science ®Google Scholar
• Thompson JM, Gallagher P, Hughes JH, et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005;186:32-40
   PubMed Web of Science ®Google Scholar
• Paradiso S, Lamberty GJ, Garvey MJ, et al. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis 1997;185:748-54
   PubMed Web of Science ®Google Scholar
• Beats BC, Sahakian BJ, Levy R. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 1996;26:591-603
   PubMed Web of Science ®Google Scholar
• Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004;5:11-25
   PubMed Web of Science ®Google Scholar
• Egan CG. Differentiation of hippocampal stem cells into functional neurons: evolving our understanding of monoamine oxidase-A inhibition. Br J Pharmacol 2006;148:563-4
   PubMed Web of Science ®Google Scholar
• Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry 2000;5:616-32
   PubMed Web of Science ®Google Scholar
• Carnitine. The science behind a conditionally essential nutrient. Proceedings of a conference. March 25 – 26, 2004. Bethesda, Maryland, USA. Ann NY Acad Sci 2004;1033:ix-xi
   Google Scholar
• Wolf G. The discovery of a vitamin role for carnitine: the first 50 years. J Nutr 2006;136:2131-4
   PubMed Web of Science ®Google Scholar
• Fraenkel G, Feiedman S. Carnitine. Vitam Horm 1957;15:73-118
   PubMed Web of Science ®Google Scholar
• Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. A-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999;22:1296-301
   PubMed Web of Science ®Google Scholar
• Liu J, Atamna H, Kuratsune H, et al. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann NY Acad Sci 2002;959:133-66
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443:787-95
   PubMed Web of Science ®Google Scholar
• Moreira PI, Santos MS, Seica R, et al. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J Neurol Sci 2007;257:206-14
   PubMed Web of Science ®Google Scholar
• Sauer J, Tabet N, Howard R. A lipoic acid for dementia. Cochrane Database Syst Rev 2004;1:CD004244
   PubMedGoogle Scholar
• Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 2004;101:10726-31
   PubMed Web of Science ®Google Scholar
• Vawter MP, Tomita H, Meng F, et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006;11:615,663-15,679
   PubMed Web of Science ®Google Scholar
• Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005;14:241-53
   PubMed Web of Science ®Google Scholar
• Konradi C, Eaton M, MacDonald ML, et al. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004;61:300-8
   PubMed Web of Science ®Google Scholar
• Beasley CL, Pennington K, Behan A, et al. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 2006;6:3414-25
   PubMed Web of Science ®Google Scholar
• Droge W, Schipper HM. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007;6:361-70
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Woldeyohannes HO, et al. Thiazolidinediones: novel treatments for cognitive deficits in mood disorders? Expert Opin Pharmacother 2007;8:1615-28
   PubMed Web of Science ®Google Scholar
• Shea TB. Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4. Neuromolecular Med 2007;9:264-9
   PubMed Web of Science ®Google Scholar
• Ancelin ML, Christen Y, Ritchie K. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geriatr Cogn Disord 2007;24:1-19
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Woldeyohannes H, et al. Thiazolidinediones: from antioxidant to neurotherapeutic? Med Hypotheses 2007;69:773-7
   PubMed Web of Science ®Google Scholar
• Bremer J. Carnitine: metabolism and functions. Physiol Rev 1983;63:1420-80
   PubMed Web of Science ®Google Scholar
• Manoli I, De Martino MU, Kino T, et al. Modulatory effects of L-carnitine on glucocorticoid receptor activity. Ann NY Acad Sci 2004;1033:147-57
   PubMed Web of Science ®Google Scholar
• Kerner J, Hoppel C. Fatty acid import into mitochondria. Biochim Biophys Acta 2000;1486:1-17
   PubMed Web of Science ®Google Scholar
• Reda E, D'Iddio S, Nicolai R, et al. The carnitine system and body composition. Acta Diabetol 2003;40(Suppl 1):S106-13
   PubMed Web of Science ®Google Scholar
• Nalecz KA, Miecz D, Berezowski V, et al. Carnitine: transport and physiological functions in the brain. Mol Aspects Med 2004;25:551-67
   PubMedGoogle Scholar
• Parnetti L, Gaiti A, Mecocci P, et al. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type. Eur J Clin Pharmacol 1992;42:89-93
   PubMed Web of Science ®Google Scholar
• Liu J, Head E, Kuratsune H, et al. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann NY Acad Sci 2004;1033:117-31
   PubMed Web of Science ®Google Scholar
• Luo Y, Packer L. Oxidative stress and age-related neurodegeneration. Boca Raton, FL: Taylor & Francis; 2006
   Google Scholar
• Hagen TM, Ingersoll RT, Wehr CM, et al. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc Natl Acad Sci USA 1998;95:9562-6
   PubMed Web of Science ®Google Scholar
• Dobbins RL, Szczepaniak LS, Bentley B, et al. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 2001;50:123-30
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Saha AK, Vavvas D, et al. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999;276:E1-18
   PubMed Web of Science ®Google Scholar
• Eaton S. Control of mitochondrial beta-oxidation flux. Prog Lipid Res 2002;41:197-239
   PubMed Web of Science ®Google Scholar
• McGarry JD. Travels with carnitine palmitoyltransferase I: from liver to germ cell with stops in between. Biochem Soc Trans 2001;29:241-5
   PubMed Web of Science ®Google Scholar
• Stephens FB, Constantin-Teodosiu D, Laithwaite D, et al. Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J 2006;20:377-9
   PubMed Web of Science ®Google Scholar
• Famularo G, De Simone C, Trinchieri V, et al. Carnitines and its congeners: a metabolic pathway to the regulation of immune response and inflammation. Ann NY Acad Sci 2004;1033:132-8
   PubMed Web of Science ®Google Scholar
• Heo YR, Kang CW, Cha YS. L-Carnitine changes the levels of insulin-like growth factors (IGFs) and IGF binding proteins in streptozotocin-induced diabetic rat. J Nutr Sci Vitaminol (Tokyo) 2001;47:329-34
   PubMed Web of Science ®Google Scholar
• Hino K, Nishikawa M, Sato E, et al. L-carnitine inhibits hypoglycemia-induced brain damage in the rat. Brain Res 2005;1053:77-87
   PubMed Web of Science ®Google Scholar
• Foster DW. The role of the carnitine system in human metabolism. Ann NY Acad Sci 2004;1033:1-16
   PubMed Web of Science ®Google Scholar
• Abdul HM, Calabrese V, Calvani M, et al. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res 2006;84:398-408
   PubMed Web of Science ®Google Scholar
• Calabrese V, Giuffrida Stella AM, Calvani M, et al. Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes. J Nutr Biochem 2006;17:73-88
   PubMed Web of Science ®Google Scholar
• Kaur J, Sharma D, Singh R. Acetyl-L-carnitine enhances Na(+), K(+)-ATPase glutathione-S-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci Lett 2001;301:1-4
   PubMed Web of Science ®Google Scholar
• Calvani M, Arrigoni-Martelli E. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int J Tissue React 1999;21:1-6
   PubMedGoogle Scholar
• Pascale A, Milano S, Corsico N, et al. Protein kinase C activation and anti-amnesic effect of acetyl-L-carnitine: in vitro and in vivo studies. Eur J Pharmacol 1994;65:1-7
   Web of Science ®Google Scholar
• Mosser DD, Morimoto RI. Molecular chaperones and the stress of oncogenesis. Oncogene 2004;23:2907-18
   PubMed Web of Science ®Google Scholar
• Haddad JJ, Saade NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 2002;133:1-19
   PubMed Web of Science ®Google Scholar
• Ghirardi O, Caprioli A, Ramacci MT, et al. Effect of long-term acetyl-L-carnitine on stress-induced analgesia in the aging rat. Exp Gerontol 1994;29:569-74
   PubMed Web of Science ®Google Scholar
• Izgut-Uysal VN, Agac A, Derin N. Effect of L-carnitine on carrageenan-induced inflammation in aged rats. Gerontology 2003;49:287-92
   PubMed Web of Science ®Google Scholar
• Winter BK, Fiskum G, Gallo LL. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 1995;72:1173-9
   PubMed Web of Science ®Google Scholar
• Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 1996;47:705-11
   PubMed Web of Science ®Google Scholar
• Brooks JO III, Yesavage JA, Carta A, et al. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach. Int Psychogeriatr 1998;10:193-203
   PubMedGoogle Scholar
• Pettegrew JW, Levine J, Gershon S, et al. 31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary results. Bipolar Disord 2002;4:61-6
   PubMed Web of Science ®Google Scholar
• Garzya G, Corallo D, Fiore A, et al. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression. Drugs Exp Clin Res 1990;16:101-6
   PubMedGoogle Scholar
• Gecele M, Francesetti G, Meluzzi A. Acetyl-L-Carnitine in aged subjects with major depression: clinical efficacy and effects on the circadian rhythm of cortisol. Dement Geriatr Cogn Disord 1991;2:333-7
   Google Scholar
• Fulgente T, Onofrj M, Del Re ML, et al. Laevo-acetylcarnitine (Nicetile registered) treatment of senile depression. Clin Trials J 1990;27:155-63
   Google Scholar
• Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging 1995;16:1-4
   PubMed Web of Science ®Google Scholar
• Bast A, Haenen GR. Lipoic acid: a multifunctional antioxidant. Biofactors 2003;17:207-13
   PubMed Web of Science ®Google Scholar
• Reed LJ, DeBusk BG, Gunsalus IC, et al. Crystalline α-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase. Science 1951;114:93-4
   PubMed Web of Science ®Google Scholar
• Fuchs J, Packer L, Zimmer G. Lipoic acid in health and disease. New York: Marcel Dekker, Inc.; 1997
   Google Scholar
• Andreassen OA, Ferrante RJ, Dedeoglu A, et al. Lipoic acid improves survival in transgenic mouse models of Huntington's disease. Neuroreport 2001;12:3371-3
   PubMed Web of Science ®Google Scholar
• Holmquist L, Stuchbury G, Berbaum K, et al. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 2007;113:154-64
   PubMed Web of Science ®Google Scholar
• Sharma M, Gupta YK. Effect of α lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur Neuropsychopharmacol 2003;13:241-7
   PubMed Web of Science ®Google Scholar
• Packer L, Witt EH, Tritschler HJ. α-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-50
   PubMed Web of Science ®Google Scholar
• Estrada DE, Ewart HS, Tsakiridis T, et al. Stimulation of glucose uptake by the natural coenzyme α-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 1996;45:1798-804
   PubMed Web of Science ®Google Scholar
• Frolich L, Gotz ME, Weinmuller M, et al. (r)-, but not (s)-α lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia. J Neural Transm 2004;111:295-310
   PubMed Web of Science ®Google Scholar
• Devasagayam TP, Di Mascio P, Kaiser S, et al. Singlet oxygen induced single-strand breaks in plasmid pBR322 DNA: the enhancing effect of thiols. Biochim Biophys Acta 1991;1088:409-12
   PubMed Web of Science ®Google Scholar
• Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Ann Rev Physiol 1995;57:737-69
   PubMed Web of Science ®Google Scholar
• Suzuki YJ, Tsuchiya M, Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 1991;15:255-63
   PubMed Web of Science ®Google Scholar
• Giedzinski E, Rola R, Fike JR, et al. Efficient production of reactive oxygen species in neural precursor cells after exposure to 250 MeV protons. Radiat Res 2005;164:540-4
   PubMed Web of Science ®Google Scholar
• Marracci GH, McKeon GP, Marquardt WE, et al. α lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J Neurosci Res 2004;78:362-70
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Lewis GF, et al. Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities. Expert Opin Pharmacother 2006;7:1305-21
   PubMedGoogle Scholar
• Quinn JF, Bussiere JR, Hammond RS, et al. Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 2007;28:213-25
   PubMed Web of Science ®Google Scholar
• Stoll S, Hartmann H, Cohen SA, et al. The potent free radical scavenger α-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol Biochem Behav 1993;46:799-805
   PubMed Web of Science ®Google Scholar
• Poon HF, Farr SA, Thongboonkerd V, et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with α-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int 2005;46:159-68
   PubMed Web of Science ®Google Scholar
• Farr SA, Poon HF, Dogrukol-Ak D, et al. The antioxidants α-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003;84:1173-83
   PubMed Web of Science ®Google Scholar
• Hagen TM, Ingersoll RT, Lykkesfeldt J, et al. (R)-α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J 1999;13:411-8
   PubMed Web of Science ®Google Scholar
• Hager K, Marahrens A, Kenklies M, et al. A-lipoic acid as a new treatment option for Azheimer type dementia. Arch Gerontol Geriatr 2001;32:275-82
   PubMed Web of Science ®Google Scholar
• Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 1998;50:645-51
   PubMed Web of Science ®Google Scholar
• Salazar MR. A lipoic acid: a novel treatment for depression. Med Hypotheses 2000;55:510-2
   PubMed Web of Science ®Google Scholar
• Ames BN, Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann NY Acad Sci 2004;1033:108-16
   PubMed Web of Science ®Google Scholar
• Liu J, Head E, Gharib AM, et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc Natl Acad Sci USA 2002;99:2356-61
   PubMed Web of Science ®Google Scholar
• Muthuswamy AD, Vedagiri K, Ganesan M, et al. Oxidative stress-mediated macromolecular damage and dwindle in antioxidant status in aged rat brain regions: role of L-carnitine and DL-α-lipoic acid. Clin Chim Acta 2006;368:84-92
   PubMed Web of Science ®Google Scholar
• Milgram NW, Head E, Zicker SC, et al. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol 2004;39:753-65
   PubMed Web of Science ®Google Scholar
• Ando S, Tadenuma T, Tanaka Y, et al. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J Neurosci Res 2001;66:266-71
   PubMed Web of Science ®Google Scholar
• Thal LJ, Calvani M, Amato A, Carta A. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD. Neurology 2000;55:805-10
   PubMed Web of Science ®Google Scholar
• Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging 1995;16:1-4
   PubMed Web of Science ®Google Scholar
• Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 1991;41:1726-32
   PubMed Web of Science ®Google Scholar
• Zanardi R, Smeraldi E. A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia. Eur Neuropsychopharmacol 2006;16:281-7
   PubMed Web of Science ®Google Scholar
• Bella R, Biondi R, Raffaele R, et al. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders. Int J Clin Pharmacol Res 1990;10:355-60
   PubMedGoogle Scholar
• Nasca D, Zurria G, Aguglia E. Actions of acetyl-l-carnitine in association with mianserine on depressed old people. New Trends Clin Neuropharmacol 1989;3:225-30
   Google Scholar
• De Simone C, Catania S, Trinchieri V, et al. Amelioration of the depression of HIV-infected subjects with L-acetyl carnitine therapy. J Drug Dev 1988;3:163-6
   Google Scholar
• Tempesta E, Casella L, Pirrongelli C, et al. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo. Drugs Exp Clin Res 1987;13:417-23
   PubMedGoogle Scholar
• Villardita C, Smirni P, Vecchio I. Acetyl-l-carnitine in depressed geriatric patients. European review for medical and pharmacological sciences 1983;6:1-12
   Google Scholar
• Biessels GJ, Smale S, Duis SE, et al. The effect of gamma-linolenic acid-α-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. J Neurol Sci 2001;182:99-106
   PubMed Web of Science ®Google Scholar
• Hudson S, Tabet N. Acetyl-L-carnitine for dementia.Cochrane Database Syst Rev 2003;(2):CD003158
   Google Scholar
• Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol 2003;18(2):61-71
   PubMed Web of Science ®Google Scholar